Polyvinylidene Fluoride (PVDF) Syringe Filters - SF18032
Biopharmaceutical and microbiological laboratories demand ultrafiltration technology capable of removing mycoplasma and submicron contaminants from critical pharmaceutical formulations while maintaining compatibility with organic solvents and aggressive chemical environments encountered in drug manufacturing processes. Advanced polyvinylidene fluoride membrane technology with 0.1 µm pore size delivers mycoplasma removal capability through ultrafine filtration performance that exceeds standard sterile-grade specifications while preserving low protein binding characteristics essential for biological sample processing. Furthermore, the 25mm diameter configuration with 4.08 cm² filtration area enables efficient processing of 10-100 ml sample volumes, making this design ideal for pharmaceutical development and quality control applications requiring submicron particle removal and microbial control beyond conventional sterile filtration capabilities.
Key PVDF Membrane Characteristics
- Hydrophobic surface chemistry requires pre-wetting with alcohols or compatible solvents before aqueous processing, optimizing performance for organic pharmaceutical formulations
- 0.1 µm pore size removes mycoplasma and submicron particles, providing critical filtration for cell culture applications and pharmaceutical manufacturing requiring ultrafine contamination control
- Exceptional chemical resistance maintains compatibility with aggressive organic solvents, including chlorinated compounds, alcohols, and aromatic hydrocarbons across pharmaceutical workflows
- Low protein binding affinity preserves therapeutic protein concentration during ultrafiltration, minimizing product loss in biopharmaceutical development and manufacturing applications
- Thermal stability to 60°C with autoclave capability at 121°C provides sterilization options for contamination-free processing in regulated pharmaceutical environments
Key Construction Characteristics
- 100 µL holdup volume minimizes loss of valuable pharmaceutical compounds and biological materials, optimizing yield for medium-volume sample processing applications
- Polypropylene housing delivers structural integrity to 87 psi maximum operating pressure with gamma sterilization compatibility for aseptic manufacturing environments
- Dual Luer-Lok and Luer-Slip connections accommodate standard syringes without adapters, streamlining integration into pharmaceutical processing and analytical workflows
- Integrated polypropylene prefilter extends membrane lifetime by capturing larger particulates upstream, reducing filter consumption in high-particulate pharmaceutical sample s
Pharmaceutical and biotechnology laboratories processing critical biological samples require ultrafiltration technology that combines mycoplasma removal with chemical resistance and minimal protein loss. PVDF syringe filters deliver 0.1 µm ultrafiltration performance through hydrophobic membrane chemistry and integrated prefilter design. Optimized for your challenging pharmaceutical workflows, this filtration solution provides workflow efficiency with validated mycoplasma retention, broad solvent compatibility, and low protein binding for biopharmaceutical manufacturing, cell culture processing, and quality control applications requiring submicron particle removal beyond conventional sterile-grade specifications.
For more information about chemical and material compatibility, please review our Chemical Compatibility Chart.
- Bubble Point (psi)
- 26.1psi
- Connection Type
- Luer-Lok/ Luer Slip
- Diameter
- 25mm
- Filtration Area
- 4.08cm²
- Flow Rate
- 8ml
- Holdup Volume
- 100μL
- Material
- Polyvinylidene Fluoride (PVDF)
- Maximum Operating Pressure
- 87psi
- Maximum Operating Temperature (°C)
- 60°C
- Membrane Thickness (µm)
- 100-130μm
- Pack Count
- 100
- Pore Size (µm)
- 0.1
- Prefilter (Yes/No)
- Yes
- Prefilter Material
- PP
- Sterility
- Nonsterile
- Sterilization
- Autoclave at 121°C for 30min/ gamma 25kGy
- Volume Throughput (ml)
- 50ml
- Wetability
- Hydrophobic
- Mycoplasma Removal - Eliminates mycoplasma contamination from cell culture media and biological buffers for biopharmaceutical manufacturing and research
- Cell Culture Media Sterilization - Provides ultrafine filtration for serum supplements and growth factors requiring submicron contamination control in bioprocessing
- Pharmaceutical Formulation Processing - Filters drug solutions and parenteral formulations requiring mycoplasma removal in small-batch pharmaceutical production
- Virus Removal Studies - Supports viral clearance validation studies in biopharmaceutical development requiring submicron filtration performance
- Liposome and Nanoparticle Clarification - Processes pharmaceutical nanoformulations requiring ultrafine particle removal without compromising product integrity
- Biotechnology QC Testing - Filters biological samples for mycoplasma testing and contamination analysis in pharmaceutical quality control laboratories